PARMODIA is contraindicated: In patients with known hypersensitivity to pemafibrate or to any of the excipients; In patients with severe hepatic disorder, Child-Pugh grade B or C cirrhosis, or biliary obstruction; In patients with cholelithiasis; In pregnant or possibly pregnant women; In patients receiving concomitant cyclosporine or rifampicin.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
